200 related articles for article (PubMed ID: 27451875)
1. The clinical management and outcomes of cervical neuroblastic tumors.
Jackson JR; Tran HC; Stein JE; Shimada H; Patel AM; Marachelian A; Kim ES
J Surg Res; 2016 Jul; 204(1):109-13. PubMed ID: 27451875
[TBL] [Abstract][Full Text] [Related]
2. The Clinical Management and Outcomes of Pelvic Neuroblastic Tumors.
Zobel M; Zamora A; Sura A; Wang L; Stein J; Marachelian A; Kim ES
J Surg Res; 2020 May; 249():8-12. PubMed ID: 31918331
[TBL] [Abstract][Full Text] [Related]
3. Histopathology (International Neuroblastoma Pathology Classification) and MYCN status in patients with peripheral neuroblastic tumors: a report from the Children's Cancer Group.
Goto S; Umehara S; Gerbing RB; Stram DO; Brodeur GM; Seeger RC; Lukens JN; Matthay KK; Shimada H
Cancer; 2001 Nov; 92(10):2699-708. PubMed ID: 11745206
[TBL] [Abstract][Full Text] [Related]
4. [Correlation between typing of peripheral neuroblastic tumors and prognosis: a clinicopathologic study of 135 cases].
YIN MZ; ZHANG ZD; MA J; SHEN P; CHEN JF; ZHANG HZ
Zhonghua Bing Li Xue Za Zhi; 2011 Mar; 40(3):151-5. PubMed ID: 21575383
[TBL] [Abstract][Full Text] [Related]
5. [Clinicopathologic features of peripheral neuroblastic tumors].
Yang BF; Fu LB; He LJ
Zhonghua Bing Li Xue Za Zhi; 2013 May; 42(5):305-10. PubMed ID: 24004586
[TBL] [Abstract][Full Text] [Related]
6. Primary pediatric neuroblastic tumors of the neck.
Moukheiber AK; Nicollas R; Roman S; Coze C; Triglia JM
Int J Pediatr Otorhinolaryngol; 2001 Aug; 60(2):155-61. PubMed ID: 11518594
[TBL] [Abstract][Full Text] [Related]
7. International neuroblastoma pathology classification for prognostic evaluation of patients with peripheral neuroblastic tumors: a report from the Children's Cancer Group.
Shimada H; Umehara S; Monobe Y; Hachitanda Y; Nakagawa A; Goto S; Gerbing RB; Stram DO; Lukens JN; Matthay KK
Cancer; 2001 Nov; 92(9):2451-61. PubMed ID: 11745303
[TBL] [Abstract][Full Text] [Related]
8. TrkA expression in peripheral neuroblastic tumors: prognostic significance and biological relevance.
Shimada H; Nakagawa A; Peters J; Wang H; Wakamatsu PK; Lukens JN; Matthay KK; Siegel SE; Seeger RC
Cancer; 2004 Oct; 101(8):1873-81. PubMed ID: 15386308
[TBL] [Abstract][Full Text] [Related]
9. Clinical and surgical outcome differences on the basis of pathology category in cervical neuroblastic tumors.
Liu Q; Wang S; Chu P; Sun J; Jin Y; Guo Y; Ma X; He L; Su Y; Zhang J; Peng Y; Li Y; Zhang X; Sun N; Liu Z; Ni X
J Pediatr Surg; 2022 Dec; 57(12):926-933. PubMed ID: 35961818
[TBL] [Abstract][Full Text] [Related]
10. Natural history and biology of stage A neuroblastoma: a Pediatric Oncology Group Study.
Alvarado CS; London WB; Look AT; Brodeur GM; Altmiller DH; Thorner PS; Joshi VV; Rowe ST; Nash MB; Smith EI; Castleberry RP; Cohn SL
J Pediatr Hematol Oncol; 2000; 22(3):197-205. PubMed ID: 10864050
[TBL] [Abstract][Full Text] [Related]
11. Cytopathological spectrum of peripheral neuroblastic tumours in fine needle aspiration cytology and categorisation as per International Neuroblastoma Pathology Classification.
Koshy A; Jain R; Srinivasan R; Bhatia P; Kakkar N; Rajwanshi A; Gupta N; Dey P; Trehan A; Bansal D
Cytopathology; 2019 Nov; 30(6):634-643. PubMed ID: 31231909
[TBL] [Abstract][Full Text] [Related]
12. Galectin-3 is a marker of favorable prognosis and a biologically relevant molecule in neuroblastic tumors.
Veschi V; Petroni M; Bartolazzi A; Altavista P; Dominici C; Capalbo C; Boldrini R; Castellano A; McDowell HP; Pizer B; Frati L; Screpanti I; Gulino A; Giannini G
Cell Death Dis; 2014 Mar; 5(3):e1100. PubMed ID: 24603328
[TBL] [Abstract][Full Text] [Related]
13. High incidence of MYCN amplification in a Moroccan series of neuroblastic tumors: comparison to current biological data.
Tabyaoui I; Tahiri-Jouti N; Serhier Z; El Maani K; Cherkaoui S; Al Zemmouri M; Othmani MB; Zamiati S
Diagn Mol Pathol; 2013 Jun; 22(2):112-8. PubMed ID: 23628823
[TBL] [Abstract][Full Text] [Related]
14. Minimally invasive surgery of neuroblastic tumors in children: Indications depend on anatomical location and image-defined risk factors.
Irtan S; Brisse HJ; Minard-Colin V; Schleiermacher G; Canale S; Sarnacki S
Pediatr Blood Cancer; 2015 Feb; 62(2):257-261. PubMed ID: 25284263
[TBL] [Abstract][Full Text] [Related]
15. Extra-adrenal peripheral neuroblastic tumors: A clinicopathological study of 18 cases.
Shankaralingappa S; Patra S; Gami A; Trivedi P; Chalaliya AK
Indian J Pathol Microbiol; 2023; 66(2):278-285. PubMed ID: 37077068
[TBL] [Abstract][Full Text] [Related]
16. Characteristics of benign neuroblastic tumors: Is surgery always necessary?
Whitlock RS; Mehl SC; Larson SK; Foster JH; Hicks J; Nuchtern JG; Sher AC; Vasudevan SA; Naik-Mathuria B
J Pediatr Surg; 2022 Aug; 57(8):1538-1543. PubMed ID: 34281709
[TBL] [Abstract][Full Text] [Related]
17. Enlarged and prominent nucleoli may be indicative of MYCN amplification: a study of neuroblastoma (Schwannian stroma-poor), undifferentiated/poorly differentiated subtype with high mitosis-karyorrhexis index.
Kobayashi C; Monforte-Munoz HL; Gerbing RB; Stram DO; Matthay KK; Lukens JN; Seeger RC; Shimada H
Cancer; 2005 Jan; 103(1):174-80. PubMed ID: 15549714
[TBL] [Abstract][Full Text] [Related]
18. N-Myc gene amplification is a major prognostic factor in localized neuroblastoma: results of the French NBL 90 study. Neuroblastoma Study Group of the Société Francaise d'Oncologie Pédiatrique.
Rubie H; Hartmann O; Michon J; Frappaz D; Coze C; Chastagner P; Baranzelli MC; Plantaz D; Avet-Loiseau H; Bénard J; Delattre O; Favrot M; Peyroulet MC; Thyss A; Perel Y; Bergeron C; Courbon-Collet B; Vannier JP; Lemerle J; Sommelet D
J Clin Oncol; 1997 Mar; 15(3):1171-82. PubMed ID: 9060561
[TBL] [Abstract][Full Text] [Related]
19. Image-defined risk factor assessment of neurogenic tumors after neoadjuvant chemotherapy is useful for predicting intra-operative risk factors and the completeness of resection.
Irtan S; Brisse HJ; Minard-Colin V; Schleiermacher G; Galmiche-Rolland L; Le Cossec C; Elie C; Canale S; Michon J; Valteau-Couanet D; Sarnacki S
Pediatr Blood Cancer; 2015 Sep; 62(9):1543-9. PubMed ID: 25820608
[TBL] [Abstract][Full Text] [Related]
20. Complete resection is not required in patients with neuroblastoma under 1 year of age.
Kaneko M; Iwakawa M; Ikebukuro K; Ohkawa H
J Pediatr Surg; 1998 Nov; 33(11):1690-4. PubMed ID: 9856897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]